Gritstone's self-amplifying mRNA vaccination protected against SARS-CoV-2 challenge in NHPs Nov. 10, 2021
synTac platform delivers primary and costimulatory signals to activate virus-specific immune T cells Nov. 10, 2021
CN Bio and iiCON partner to validate novel organ-on-a-chip infection models for COVID-19 Nov. 10, 2021
Unveiling the evolutionary acquisition of antifungal drug resistance in Candida glabrata Nov. 9, 2021
MM-3122, a novel TMPRSS2 inhibitor with antiviral activity against SARS-CoV-2 and MERS-CoV Nov. 5, 2021